Phyto Chem Approves Q3FY26 Financial Results

Phyto Chem (India) Limited's Board approved unaudited financial results for Q3FY26 and nine months ended December 31, 2025, following regulatory compliance under SEBI regulations.

Phyto Chem Board Meet Set for Feb 14 for Q3FY26 Results

Phyto Chem (India) Limited announces board meeting on February 14, 2026 to consider Q3FY26 unaudited financial results for quarter ended December 31, 2025. Trading window closed from January 1, 2026.

PhytoChem India Reports Net Loss of Rs 104.20 Lakhs in Q2 FY2026

PhytoChem (India) Limited posted a net loss of Rs 55.76 lakhs for Q2 ended September 30, 2025, bringing the half-year loss to Rs 104.20 lakhs compared to a profit of Rs 44.42 lakhs in the same quarter last year. The company's revenue from operations declined to Rs 150.32 lakhs in Q2 from Rs 206.77 lakhs in the previous quarter, with total expenses of Rs 206.96 lakhs exceeding revenues.

Phyto Chem (India) Limited Reports Loss and Major Board Changes in Q1 Results

Phyto Chem (India) Limited reported a net loss of Rs 48.45 lakhs for the first quarter ended June 30, 2025, compared to a loss of Rs 146.82 lakhs in the same period last year. Revenue from operations decreased to Rs 150.32 lakhs from Rs 460.79 lakhs year-over-year. The company's board approved significant leadership changes including the retirement of Dr. Y. Venkateswarlu as Non-Executive Director, cessation of Dr. G.S.R. Anjaneyulu as Independent Director due to completion of two consecutive terms, and resignation of Mr. P. Anjaneyulu as Non-Executive Director. Three new directors were appointed: Mr. K. Srinivasa Rao as Additional Non-Executive Director, Mr. Sreemannarayana Yarlagadda as Additional Executive Director, and Mr. Sudhakar Nadendla as Additional Independent Director. The board also approved re-appointments of internal and secretarial auditors, withdrew a proposal to increase authorized share capital citing market conditions, and finalized preparations for the 36th Annual General Meeting.